Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Approvable letter for Extravan for glaucoma

Sep. 21, 2004

No Comments

Novel VAP-1 inhibitors and their use in macular edema described by Fujisawa

Sep. 15, 2004

No Comments

Sirna Therapeutics files IND to advance Sirna-027 into clinic

Sep. 9, 2004

No Comments

Gatiflo eye drops launched in Japan

Sep. 8, 2004

No Comments

Macugen NDA accepted for review

Aug. 23, 2004

No Comments

Pfizer scientists describe new antiangiogenic agents for ocular disorders

Aug. 19, 2004

No Comments

Acuity files IND for phase I trials of Cand5

Aug. 16, 2004

No Comments

Approvable letter for ZyLET

Aug. 11, 2004

No Comments

Hybridon licenses VEGF rights to Alnylam for ocular indications

Aug. 10, 2004

No Comments

Ista submits sNDA for Vitrase as spreading agent

Aug. 10, 2004

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Approvable letter for Extravan for glaucoma

Novel VAP-1 inhibitors and their use in macular edema described by Fujisawa

Sirna Therapeutics files IND to advance Sirna-027 into clinic

Gatiflo eye drops launched in Japan

Macugen NDA accepted for review

Pfizer scientists describe new antiangiogenic agents for ocular disorders

Acuity files IND for phase I trials of Cand5

Approvable letter for ZyLET

Hybridon licenses VEGF rights to Alnylam for ocular indications

Ista submits sNDA for Vitrase as spreading agent

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Ocular RSS

Ocular
RSS